...
首页> 外文期刊>Molecular biology reports >Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy
【24h】

Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy

机译:Nogo-66受体在人类星形细胞瘤中的表达与肿瘤恶性程度相关

获取原文
获取原文并翻译 | 示例
           

摘要

Nogo-A is a myelin-associated neuronal growth inhibitory molecule in central nervous system after trauma. However, the physiological functions of Nogo-A in neural development and in healthy oligodendrocytes are largely unknown. In this study, we investigated the expression of Nogo-66 receptor (NgR) protein in 60 cases of human astrocytoma by Western blot RT-PCR and immunohistochemistry. The correlation between the expression of NgR and pathologic grades of astrocyoma was further analyzed. The results showed that the expression of NgR protein and NgR mRNA immunoreactivity score, were decreased markedly with the increasing pathological grades. Double immunostaining results showed that Nogo-A and NgR were colocalized at the interface of astrocytoma cells and extracellular matrix. Our results indicated that NgR may have inhibitory effects on tumor activity and Nogo-A may restrict migration of tumor cells via NgR.
机译:Nogo-A是创伤后中枢神经系统中与髓磷脂相关的神经元生长抑制分子。但是,Nogo-A在神经发育和健康少突胶质细胞中的生理功能在很大程度上是未知的。在这项研究中,我们通过蛋白质印迹RT-PCR和免疫组化研究了Nogo-66受体(NgR)蛋白在60例人类星形细胞瘤中的表达。进一步分析了NgR的表达与星形细胞瘤病理分级之间的相关性。结果表明,随着病理等级的升高,NgR蛋白的表达和NgR mRNA的免疫反应评分明显降低。双重免疫染色结果表明,Nogo-A和NgR共定位在星形细胞瘤细胞和细胞外基质的界面上。我们的结果表明,NgR可能对肿瘤活性具有抑制作用,而Nogo-A可能通过NgR限制肿瘤细胞的迁移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号